“I want to thank John for his many contributions to Tandem over the past 10 years and wish him the best of luck in his future endeavors,” said Kim Blickenstaff, president and chief executive officer of Tandem Diabetes Care. “Leigh brings a passion for leading teams, delivering results, and providing financial stewardship and discipline that makes her ideally suited for this expanded role. With our positive sales momentum in the fourth quarter, and our anticipation of key business inflection points in 2018, we expect Leigh will play a pivotal role as we drive toward sustained profitable growth.”
Vosseller joined Tandem in September 2013 as vice president of finance. Prior to that time, she served as vice president and CFO at Genoptix Inc. (a Novartis company) beginning in 2011, after initially joining the company in 2008. Prior to that she held a senior finance position at Biosite Incorporated where she played a key role in developing the financial and administrative infrastructure for international expansion. Vosseller is a certified public accountant (inactive) and holds a bachelor’s degree in accounting from Missouri State University.
Cajigas’ retirement is not related to any disagreement with, or inaccuracy or omission in, the Company's accounting systems or financial reporting